<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2017-10-25" version="177">
<accession>P50213</accession>
<accession>D3DW83</accession>
<accession>Q9H3X0</accession>
<name>IDH3A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial</fullName>
<ecNumber evidence="7 8">1.1.1.41</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Isocitric dehydrogenase subunit alpha</fullName>
</alternativeName>
<alternativeName>
<fullName>NAD(+)-specific ICDH subunit alpha</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IDH3A</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Biochem. J." volume="308" first="63" last="68">
<title>Characterization of a cDNA clone for human NAD(+)-specific isocitrate dehydrogenase alpha-subunit and structural comparison with its isoenzymes from different species.</title>
<authorList>
<person name="Kim Y.O."/>
<person name="Oh I.U."/>
<person name="Park H.S."/>
<person name="Jeng J."/>
<person name="Song B.J."/>
<person name="Huh T.L."/>
</authorList>
<dbReference type="PubMed" id="7755589"/>
<dbReference type="DOI" id="10.1042/bj3080063"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Heart</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain cortex</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lymph</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Vishwanath V."/>
<person name="Chen W.-Q."/>
<person name="Sun Y."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 135-146; 179-188 AND 300-316</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Brain</tissue>
<tissue>Cajal-Retzius cell</tissue>
<tissue>Fetal brain cortex</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-343</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER PHE-27</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2017" name="Sci. Rep." volume="7" first="41882" last="41882">
<title>The beta and gamma subunits play distinct functional roles in the alpha2betagamma heterotetramer of human NAD-dependent isocitrate dehydrogenase.</title>
<authorList>
<person name="Ma T."/>
<person name="Peng Y."/>
<person name="Huang W."/>
<person name="Liu Y."/>
<person name="Ding J."/>
</authorList>
<dbReference type="PubMed" id="28139779"/>
<dbReference type="DOI" id="10.1038/srep41882"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>ENZYME REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>COFACTOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF TYR-153</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2017" name="Sci. Rep." volume="7" first="40921" last="40921">
<title>Molecular mechanism of the allosteric regulation of the alphagamma heterodimer of human NAD-dependent isocitrate dehydrogenase.</title>
<authorList>
<person name="Ma T."/>
<person name="Peng Y."/>
<person name="Huang W."/>
<person name="Ding J."/>
</authorList>
<dbReference type="PubMed" id="28098230"/>
<dbReference type="DOI" id="10.1038/srep40921"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.31 ANGSTROMS) OF 28-366 IN COMPLEX WITH MAGNESIUM AND CITRATE</scope>
<scope>SUBUNIT</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF GLU-152; TYR-153; LYS-169; LYS-200; ASN-202; ASP-208 AND TYR-255</scope>
</reference>
<comment type="function">
<text evidence="8">Catalytic subunit of the enzyme which catalyzes the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers.</text>
</comment>
<comment type="catalytic activity">
<text evidence="7 8">Isocitrate + NAD(+) = 2-oxoglutarate + CO(2) + NADH.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="7 8">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
<cofactor evidence="8">
<name>Mn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29035"/>
</cofactor>
<text evidence="8">Divalent metal cations; Mn(2+) or Mg(2+). Activity higher in presence of Mn(2+) than of Mg(2+). Binds 1 Mg(2+) or Mn(2+) ion per subunit.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="7 8">The heterotetramer and the heterodimer composed of IDH3A and IDH3G subunits can be allosterically activated by citrate (CIT) or/and ADP, and the two activators can act independently or synergistically. The heterodimer composed of IDH3A and IDH3B subunits cannot be allosterically regulated and the allosteric regulation of the heterotetramer is through the IDH3G subunit and not the IDH3B subunit. The IDH3G subunit contains the allosteric site which consists of a CIT-binding site and an ADP-binding site, and the binding of CIT and ADP causes conformational changes at the allosteric site which are transmitted to the active site in the catalytic subunit (IDH3A) through a cascade of conformational changes at the heterodimer interface, leading to stabilization of the isocitrate-binding at the active site and thus activation of the enzyme. ATP can activate the heterotetramer and the heterodimer composed of IDH3A and IDH3G subunits at low concentrations but inhibits their activities at high concentrations, whereas ATP exhibits only inhibitory effect on the heterodimer composed of IDH3A and IDH3B subunits.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<Vmax evidence="8">20.0 umol/min/mg enzyme with isocitrate as substrate (heterotetramer)</Vmax>
<Vmax evidence="8">10.9 umol/min/mg enzyme with isocitrate as substrate (heterodimer composed of IDH3A and IDH3B subunits)</Vmax>
<Vmax evidence="8">7.29 umol/min/mg enzyme with isocitrate as substrate (heterodimer composed of IDH3A and IDH3G subunits)</Vmax>
<Vmax evidence="8">20.7 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate (heterotetramer)</Vmax>
<Vmax evidence="8">11.2 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate (heterodimer composed of IDH3A and IDH3B subunits)</Vmax>
<Vmax evidence="8">10.0 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate (heterodimer composed of IDH3A and IDH3G subunits)</Vmax>
<Vmax evidence="8">22.1 umol/min/mg enzyme with isocitrate as substrate in the presence of ADP (heterotetramer)</Vmax>
<Vmax evidence="8">11.2 umol/min/mg enzyme with isocitrate as substrate in the presence of ADP (heterodimer composed of IDH3A and IDH3B subunits)</Vmax>
<Vmax evidence="8">9.42 umol/min/mg enzyme with isocitrate as substrate in the presence of ADP (heterodimer composed of IDH3A and IDH3G subunits)</Vmax>
<Vmax evidence="8">21.3 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate and ADP (heterotetramer)</Vmax>
<Vmax evidence="8">11.9 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate and ADP (heterodimer composed of IDH3A and IDH3B subunits)</Vmax>
<Vmax evidence="8">13.1 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate and ADP (heterodimer composed of IDH3A and IDH3G subunits)</Vmax>
<Vmax evidence="8">17.7 umol/min/mg enzyme with isocitrate as substrate in the presence of ATP (heterotetramer)</Vmax>
<Vmax evidence="8">6.62 umol/min/mg enzyme with isocitrate as substrate in the presence ATP (heterodimer composed of IDH3A and IDH3G subunits)</Vmax>
<Vmax evidence="8">17.6 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate and ATP (heterotetramer)</Vmax>
<Vmax evidence="8">8.94 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate and ATP (heterodimer composed of IDH3A and IDH3G subunits)</Vmax>
<text evidence="8">kcat is 26.7 sec(-1) for the heterotetramer with isocitrate as substrate. kcat is 14.6 sec(-1) for the heterodimer composed of IDH3A and IDH3B subunits with isocitrate as substrate. kcat is 9.72 sec(-1) for the heterodimer composed of IDH3A and IDH3G subunits with isocitrate as substrate. kcat is 23.4 sec(-1) for the heterotetramer with isocitrate as substrate in the presence of citrate and ATP. kcat is 11.9 sec(-1) for the heterodimer composed of IDH3A and IDH3G subunits with isocitrate as substrate in the presence of citrate and ATP. kcat is 28.4 sec(-1) for the heterotetramer with isocitrate as substrate in the presence of citrate and ADP. kcat is 15.8 sec(-1) for the heterodimer composed of IDH3A and IDH3B subunits with isocitrate as substrate in the presence of citrate and ADP. kcat is 17.6 sec(-1) for the heterodimer composed of IDH3A and IDH3G subunits with isocitrate as substrate in the presence of citrate and ADP.</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="7 8">Heterooligomer of subunits alpha (IDH3A), beta (IDH3B), and gamma (IDH3G) in the apparent ratio of 2:1:1. The heterodimer containing one IDH3A and one IDH3B subunit and the heterodimer containing one IDH3A and one IDH3G subunit assemble into a heterotetramer (which contains two subunits of IDH3A, one of IDH3B and one of IDH3G) and further into the heterooctamer.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Mitochondrion</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P50213-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P50213-2</id>
<name>2</name>
<sequence type="described" ref="VSP_014516"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="similarity">
<text evidence="10">Belongs to the isocitrate and isopropylmalate dehydrogenases family.</text>
</comment>
<dbReference type="EC" id="1.1.1.41" evidence="7 8"/>
<dbReference type="EMBL" id="U07681">
<property type="protein sequence ID" value="AAA85639.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL442090">
<property type="protein sequence ID" value="CAC09449.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471136">
<property type="protein sequence ID" value="EAW99181.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471136">
<property type="protein sequence ID" value="EAW99182.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021967">
<property type="protein sequence ID" value="AAH21967.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10297.1">
<molecule id="P50213-1"/>
</dbReference>
<dbReference type="PIR" id="S55282">
<property type="entry name" value="S55282"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005521.1">
<molecule id="P50213-1"/>
<property type="nucleotide sequence ID" value="NM_005530.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.591110"/>
<dbReference type="PDB" id="5GRE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=28-366"/>
</dbReference>
<dbReference type="PDB" id="5GRF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=28-366"/>
</dbReference>
<dbReference type="PDB" id="5GRH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=28-366"/>
</dbReference>
<dbReference type="PDB" id="5GRI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A=28-366"/>
</dbReference>
<dbReference type="PDB" id="5GRL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A=28-366"/>
</dbReference>
<dbReference type="PDBsum" id="5GRE"/>
<dbReference type="PDBsum" id="5GRF"/>
<dbReference type="PDBsum" id="5GRH"/>
<dbReference type="PDBsum" id="5GRI"/>
<dbReference type="PDBsum" id="5GRL"/>
<dbReference type="ProteinModelPortal" id="P50213"/>
<dbReference type="SMR" id="P50213"/>
<dbReference type="BioGrid" id="109645">
<property type="interactions" value="51"/>
</dbReference>
<dbReference type="IntAct" id="P50213">
<property type="interactions" value="11"/>
</dbReference>
<dbReference type="MINT" id="MINT-1148360"/>
<dbReference type="STRING" id="9606.ENSP00000299518"/>
<dbReference type="DrugBank" id="DB00157">
<property type="generic name" value="NADH"/>
</dbReference>
<dbReference type="iPTMnet" id="P50213"/>
<dbReference type="PhosphoSitePlus" id="P50213"/>
<dbReference type="SwissPalm" id="P50213"/>
<dbReference type="BioMuta" id="IDH3A"/>
<dbReference type="DMDM" id="1708399"/>
<dbReference type="OGP" id="P50213"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00030702"/>
<dbReference type="EPD" id="P50213"/>
<dbReference type="MaxQB" id="P50213"/>
<dbReference type="PaxDb" id="P50213"/>
<dbReference type="PeptideAtlas" id="P50213"/>
<dbReference type="PRIDE" id="P50213"/>
<dbReference type="DNASU" id="3419"/>
<dbReference type="Ensembl" id="ENST00000299518">
<molecule id="P50213-1"/>
<property type="protein sequence ID" value="ENSP00000299518"/>
<property type="gene ID" value="ENSG00000166411"/>
</dbReference>
<dbReference type="GeneID" id="3419"/>
<dbReference type="KEGG" id="hsa:3419"/>
<dbReference type="UCSC" id="uc002bdd.4">
<molecule id="P50213-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3419"/>
<dbReference type="DisGeNET" id="3419"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000166411.13"/>
<dbReference type="GeneCards" id="IDH3A"/>
<dbReference type="HGNC" id="HGNC:5384">
<property type="gene designation" value="IDH3A"/>
</dbReference>
<dbReference type="HPA" id="HPA041465"/>
<dbReference type="HPA" id="HPA062971"/>
<dbReference type="MIM" id="601149">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P50213"/>
<dbReference type="OpenTargets" id="ENSG00000166411"/>
<dbReference type="PharmGKB" id="PA29632"/>
<dbReference type="eggNOG" id="KOG0785">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0473">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00550000074918"/>
<dbReference type="HOGENOM" id="HOG000021113"/>
<dbReference type="HOVERGEN" id="HBG052080"/>
<dbReference type="InParanoid" id="P50213"/>
<dbReference type="KO" id="K00030"/>
<dbReference type="OMA" id="FQQIQTR"/>
<dbReference type="OrthoDB" id="EOG091G094X"/>
<dbReference type="PhylomeDB" id="P50213"/>
<dbReference type="TreeFam" id="TF105692"/>
<dbReference type="BioCyc" id="MetaCyc:ENSG00000166411-MONOMER"/>
<dbReference type="Reactome" id="R-HSA-71403">
<property type="pathway name" value="Citric acid cycle (TCA cycle)"/>
</dbReference>
<dbReference type="SABIO-RK" id="P50213"/>
<dbReference type="ChiTaRS" id="IDH3A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="IDH3A"/>
<dbReference type="GenomeRNAi" id="3419"/>
<dbReference type="PRO" id="PR:P50213"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 15"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000166411"/>
<dbReference type="CleanEx" id="HS_IDH3A"/>
<dbReference type="ExpressionAtlas" id="P50213">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P50213">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005759">
<property type="term" value="C:mitochondrial matrix"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0043209">
<property type="term" value="C:myelin sheath"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004449">
<property type="term" value="F:isocitrate dehydrogenase (NAD+) activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051287">
<property type="term" value="F:NAD binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005975">
<property type="term" value="P:carbohydrate metabolic process"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006099">
<property type="term" value="P:tricarboxylic acid cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR019818">
<property type="entry name" value="IsoCit/isopropylmalate_DH_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR004434">
<property type="entry name" value="Isocitrate_DH_NAD"/>
</dbReference>
<dbReference type="InterPro" id="IPR024084">
<property type="entry name" value="IsoPropMal-DH-like_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00180">
<property type="entry name" value="Iso_dh"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01329">
<property type="entry name" value="Iso_dh"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00175">
<property type="entry name" value="mito_nad_idh"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00470">
<property type="entry name" value="IDH_IMDH"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0464">Manganese</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0809">Transit peptide</keyword>
<keyword id="KW-0816">Tricarboxylic acid cycle</keyword>
<feature type="transit peptide" description="Mitochondrion" evidence="5">
<location>
<begin position="1"/>
<end position="27"/>
</location>
</feature>
<feature type="chain" description="Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial" id="PRO_0000014436">
<location>
<begin position="28"/>
<end position="366"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium or manganese" evidence="7">
<location>
<position position="233"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium or manganese" evidence="7">
<location>
<position position="257"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium or manganese" evidence="7">
<location>
<position position="261"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="7">
<location>
<position position="115"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="7">
<location>
<position position="125"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="7">
<location>
<position position="146"/>
</location>
</feature>
<feature type="site" description="Critical for catalysis" evidence="7 8">
<location>
<position position="153"/>
</location>
</feature>
<feature type="site" description="Critical for catalysis" evidence="7">
<location>
<position position="200"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine" evidence="6">
<location>
<position position="77"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="101"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="6">
<location>
<position position="223"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="4">
<location>
<position position="343"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="6">
<location>
<position position="343"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine" evidence="6">
<location>
<position position="350"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_014516" evidence="9">
<location>
<begin position="1"/>
<end position="78"/>
</location>
</feature>
<feature type="mutagenesis site" description="No significant effect on the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP." evidence="7">
<original>E</original>
<variation>A</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of activity of the heterotetramer, heterodimer composed of IDH3A and IDH3B subunits and the heterodimer composed of IDH3A and IDH3G subunits with no effect on their oligomeric states." evidence="8">
<original>Y</original>
<variation>F</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP." evidence="7">
<original>K</original>
<variation>A</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate." evidence="7">
<original>K</original>
<variation>A</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate." evidence="7">
<original>N</original>
<variation>A</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP." evidence="7">
<original>D</original>
<variation>A</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP." evidence="7">
<original>Y</original>
<variation>A</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="32"/>
<end position="37"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="43"/>
<end position="56"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="60"/>
<end position="65"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="82"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="93"/>
<end position="96"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="110"/>
<end position="118"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="122"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="131"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="141"/>
<end position="147"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="149"/>
<end position="151"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="157"/>
<end position="161"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="164"/>
<end position="172"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="173"/>
<end position="189"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="194"/>
<end position="199"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="201"/>
<end position="203"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="205"/>
<end position="220"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="225"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="232"/>
<end position="239"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="243"/>
<end position="245"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="248"/>
<end position="251"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="253"/>
<end position="267"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="270"/>
<end position="272"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="275"/>
<end position="278"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="280"/>
<end position="282"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="284"/>
<end position="287"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="294"/>
<end position="296"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="297"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="305"/>
<end position="318"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="321"/>
<end position="337"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="338"/>
<end position="340"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="343"/>
<end position="345"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="351"/>
<end position="363"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5GRE"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5GRF"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5GRI"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25944712"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9D6R2"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28098230"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28139779"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000305"/>
<sequence length="366" mass="39592" checksum="695F6A34F97430CF" modified="1996-10-01" version="1" precursor="true">
MAGPAWISKVSRLLGAFHNPKQVTRGFTGGVQTVTLIPGDGIGPEISAAVMKIFDAAKAP
IQWEERNVTAIQGPGGKWMIPSEAKESMDKNKMGLKGPLKTPIAAGHPSMNLLLRKTFDL
YANVRPCVSIEGYKTPYTDVNIVTIRENTEGEYSGIEHVIVDGVVQSIKLITEGASKRIA
EFAFEYARNNHRSNVTAVHKANIMRMSDGLFLQKCREVAESCKDIKFNEMYLDTVCLNMV
QDPSQFDVLVMPNLYGDILSDLCAGLIGGLGVTPSGNIGANGVAIFESVHGTAPDIAGKD
MANPTALLLSAVMMLRHMGLFDHAARIEAACFATIKDGKSLTKDLGGNAKCSDFTEEICR
RVKDLD
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>